These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30760618)

  • 1. Oral Treatment with BT-11 Ameliorates Inflammatory Bowel Disease by Enhancing Regulatory T Cell Responses in the Gut.
    Leber A; Hontecillas R; Zoccoli-Rodriguez V; Chauhan J; Bassaganya-Riera J
    J Immunol; 2019 Apr; 202(7):2095-2104. PubMed ID: 30760618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of LANCL2 by BT-11 Ameliorates IBD by Supporting Regulatory T Cell Stability Through Immunometabolic Mechanisms.
    Leber A; Hontecillas R; Zoccoli-Rodriguez V; Bassaganya-Riera J
    Inflamm Bowel Dis; 2018 Aug; 24(9):1978-1991. PubMed ID: 29718324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial.
    Leber A; Hontecillas R; Zoccoli-Rodriguez V; Colombel JF; Chauhan J; Ehrich M; Farinola N; Bassaganya-Riera J
    Inflamm Bowel Dis; 2020 Mar; 26(4):643-652. PubMed ID: 31077582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
    Daniel C; Sartory N; Zahn N; Geisslinger G; Radeke HH; Stein JM
    J Immunol; 2007 Feb; 178(4):2458-68. PubMed ID: 17277153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production.
    Yu L; Yang F; Zhang F; Guo D; Li L; Wang X; Liang T; Wang J; Cai Z; Jin H
    Cell Death Dis; 2018 Sep; 9(9):905. PubMed ID: 30185773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis.
    Chen J; Xie L; Toyama S; Hünig T; Takahara S; Li XK; Zhong L
    Int Immunopharmacol; 2011 May; 11(5):610-7. PubMed ID: 21163250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis.
    Abron JD; Singh NP; Mishra MK; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP
    Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G220-G230. PubMed ID: 29672155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
    Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
    Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
    Huang H; Dawicki W; Zhang X; Town J; Gordon JR
    J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
    Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
    Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance.
    Li Q; Shan Q; Sang X; Zhu R; Chen X; Cao G
    Am J Chin Med; 2019; 47(1):177-201. PubMed ID: 30612460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iguratimod ameliorates inflammatory responses by modulating the Th17/Treg paradigm in dextran sulphate sodium-induced murine colitis.
    Jiang XP; Huang XL; Yang ZP; Wang SC; Xie W; Miao L; Tang L; Huang ZM
    Mol Immunol; 2018 Jan; 93():9-19. PubMed ID: 29121519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of ROCK2 activity in facilitating mucosal CD4
    Yang W; Zhou G; Yu T; Chen L; Yu L; Guo Y; Cong Y; Liu Z
    J Autoimmun; 2018 May; 89():125-138. PubMed ID: 29269245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells.
    Fujimoto M; Nakano M; Terabe F; Kawahata H; Ohkawara T; Han Y; Ripley B; Serada S; Nishikawa T; Kimura A; Nomura S; Kishimoto T; Naka T
    J Immunol; 2011 Jan; 186(1):32-40. PubMed ID: 21106853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis.
    Yang J; Xu L
    Med Sci Monit; 2016 Aug; 22():2785-92. PubMed ID: 27498708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4
    Wan Q; Liu Z; Yang M; Wu J
    Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells.
    Uraushihara K; Kanai T; Ko K; Totsuka T; Makita S; Iiyama R; Nakamura T; Watanabe M
    J Immunol; 2003 Jul; 171(2):708-16. PubMed ID: 12847237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease.
    Gentili M; Ronchetti S; Ricci E; Di Paola R; Gugliandolo E; Cuzzocrea S; Bereshchenko O; Migliorati G; Riccardi C
    Pharmacol Res; 2019 Mar; 141():21-31. PubMed ID: 30552973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
    Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
    Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.